Private Advisor Group LLC Acquires 457 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Private Advisor Group LLC increased its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 15.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,380 shares of the company’s stock after purchasing an additional 457 shares during the period. Private Advisor Group LLC’s holdings in Prestige Consumer Healthcare were worth $244,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in PBH. Opal Wealth Advisors LLC acquired a new stake in Prestige Consumer Healthcare in the 2nd quarter worth about $26,000. Quest Partners LLC increased its stake in Prestige Consumer Healthcare by 2,826.7% in the second quarter. Quest Partners LLC now owns 439 shares of the company’s stock valued at $30,000 after acquiring an additional 424 shares during the last quarter. EverSource Wealth Advisors LLC raised its position in Prestige Consumer Healthcare by 80.6% during the first quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock valued at $33,000 after purchasing an additional 208 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its stake in Prestige Consumer Healthcare by 562.3% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 510 shares of the company’s stock worth $35,000 after purchasing an additional 433 shares during the last quarter. Finally, Gladius Capital Management LP bought a new stake in Prestige Consumer Healthcare during the second quarter worth $35,000. 99.95% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

PBH has been the subject of several recent research reports. DA Davidson upped their price objective on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Wednesday, August 28th. Jefferies Financial Group reaffirmed a “hold” rating and set a $76.00 price target (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $94.20.

Prestige Consumer Healthcare Stock Up 3.1 %

Shares of Prestige Consumer Healthcare stock opened at $80.07 on Friday. The stock’s 50-day moving average is $72.43 and its 200 day moving average is $69.78. Prestige Consumer Healthcare Inc. has a one year low of $56.61 and a one year high of $81.25. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.23 and a quick ratio of 1.90. The firm has a market cap of $3.97 billion, a price-to-earnings ratio of 19.58, a PEG ratio of 2.08 and a beta of 0.47.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings data on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, beating analysts’ consensus estimates of $0.86 by $0.04. The firm had revenue of $267.10 million for the quarter, compared to analyst estimates of $260.54 million. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. The business’s quarterly revenue was down 4.4% compared to the same quarter last year. During the same period last year, the firm earned $1.06 earnings per share. Equities research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.43 EPS for the current year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.